This patent application claims benefit of German Patent Application No. 10 2018 120 533.3, filed Aug. 23, 2018, which patent application is hereby incorporated herein by reference.
The invention refers to ventilating appliances in general, and more particularly to a ventilating appliance comprising a ventilating device having an air outlet channel and an air inlet channel, two hoses which are connected to one of the two channels of the ventilating device, and an air distributor on which three openings are provided, which are coupled to one of the two hoses of the ventilating device and to a tube which can be inserted into the mouth or nose space of a living being.
Such ventilating appliances have been known for many years and are usually used for living beings, especially people, who can no longer breathe independently. The ventilating device assigned to the ventilating appliance generates an intermittent air flow, which can also be enriched with oxygen and other gases, for example. This air flow is passed through a ventilating tube and an air distributor to a tube connected to it, which is inserted into the lung area of the patient. The breathing air generated by the ventilating device thus reaches the patient's lungs. When the patient exhales, the consumed breathing air is sucked through the tube into the air distributor and from there back into the ventilating device.
In such treatment situations, it has been found that the patient's lung area becomes mucous, especially if the patient has to be ventilated for a relatively long period of time. However, occluding the lungs can cause infections and breathing difficulties that can be life-threatening.
Although EP 2 489 413 B1 discloses a therapy device for the treatment of respiratory diseases in patients, the respiratory tract therapy devices of prior art can only be used for patients who can breathe independently. Such therapy devices cannot be used for patients who can no longer breathe independently and must therefore be connected to a ventilating device of prior art. The air resistances generated within the therapy device during inhalation and/or exhalation cause oscillating air pressure fluctuations, which are transmitted to the bronchial and lung areas of the patient and have an expectorant effect there. As a result, the mucus released from the lungs can be degenerated or removed independently. The so-called PEP or OPeP therapy devices, by means of which positive expiratory pressure (PEP) or oscillating positive expiratory pressure (OPEP) ventilating treatments can be carried out, generate a positive and negative ventilating pressure, through which the mucus deposited in the lungs can be released and transported out of them.
The combination of the known respiratory tract therapy devices, which work according to the treatment principle described above, and the known ventilating appliances have not been disclosed. Rather, the mucus in the lungs of the patient who is not breathing independently is loosened surgically or by other medical measures and transported away, as a result of which, however, a high risk of infection or respiratory arrest exists, because the patient is uncoupled from the ventilating device—at least for a short time —and foreign objects must be used for releasing the mucus and removing it.
It is therefore the task of the present invention to develop the aforementioned ventilating appliances in such a way that a patient to be ventilated undergoes a release of mucus and its removal from the lung area with cost-effective measures, without the need for foreign objects or switching off the ventilating appliance.
This task is accomplished according to the invention by the features of the characterizing part of patent claim 1.
Further advantageous embodiments of the invention are described in the subordinate claims.
The fact that a respiratory tract therapy device is used in the inhalation tube, that an air flow is generated by the end in the respiratory tract therapy device, through which an intermittent air pressure fluctuation arises in the respiratory tract therapy device, and that the air pressure fluctuations generated in this way are passed on or transmitted in the bronchial and lung region of the living beings, means that both positive and negative air pressures act on the pulmonary alveoli, as a result of which mucus deposits are released and removed. Consequently, the ventilating appliance according to the present invention can also be used for living beings which cannot breathe independently but require medical assistance in the form of artificial or mechanical ventilation. Such a medical treatment measure advantageously leads to the fact that the patients connected to the ventilating appliance have no or only very little mucus deposition in their bronchial and lung areas, since the permanent air pressure fluctuations caused by the air flow generated by the ventilating device and the design of the respiratory tract therapy device cause the mucus to be released and at the same time these mucus particles can be breathed out or exhaled by the patient.
The respiratory tract therapy device can consist of a curved tube in which a freely movable hose is fixed, or it can be designed as a valve in the form of a throttle valve or a ball. A decisive factor for the generation of positive and negative air pressure fluctuations within the respiratory tract therapy device is that the respiratory air uniformly generated by the ventilating device and pressed into the tube of the respiratory tract therapy device has an oscillating pressure level, resulting in corresponding air pressure fluctuations within the patient's lungs or bronchi. The oscillating air bridge generated in this way causes foreign particles, in particular mucus, to separate from the alveoli and be transported outwards with the extracted breathing air.
Since a patient often does not permanently need the oscillating air pressure fluctuations generated by the respiratory tract therapy device, it is advantageous if the respiratory tract therapy device can be removed or installed from the ventilating hose of the ventilating appliance without loss of time and without complications. For this purpose, the two ends of the tube piece are equipped with corresponding fastening adapters which can be plugged together into corresponding fastening adapters associated with or attached to the ventilating hose so that the tube piece can be clipped or threaded together with the free ends of the ventilating hose.
In an advantageous embodiment, the fastening adapters on the ventilating hose are configured in such a way that they can be assembled with an airtight seal when the respiratory tract therapy device is removed from the ventilating hose.
A particularly advantageous further embodiment of the present invention is to provide a bypass line parallel to the respiratory tract therapy device, which can be controlled via a valve. When the valve is set to an open position, the air generated by the ventilating device flows directly through the bypass line to the patient. When the valve is closed, the air generated by the ventilating device flows through the respiratory tract therapy device, creating the desired intermittent variations in air pressure that enter the bronchi or lungs of the living being and cause the mucus to be released.
The drawings show two examples of a ventilating appliance according to the present invention, which are explained in more detail below. In the drawings,
The ventilating appliance 1 consists of a ventilating device 2, through which breathing air is generated and directed towards an air outlet channel 3. In addition, an air inlet channel 4 is provided on the ventilating device 2. A ventilating hose 5 is attached to the air outlet channel 3 and an exhalation hose 6 is attached to the air inlet channel 4. The ventilating hose 5 can also be referred to as the inhalation leg or coaxial hose.
In addition, an air distributor 7 with three openings 8, 9 and 10 is assigned to the ventilating appliance 1. The ventilating hose 5 is connected to the opening 8, the exhalation hose 6 to the opening 9 and a tube 11 to the opening 10. The tube 11 is introduced into the lung area 23 through the mouth cavity 22 of the living being 21, so that the breathing air 18 produced by the ventilating device 2 is pressed into the lung 23 through the ventilating hose 5, the air distributor 7 and the tube 11, in which case the patient 21 is artificially ventilated. The consumed breathing air 13 is sucked out of the lung 23 within a given cycle by the ventilating device 2 and the air passes via the tube 11 and the air distributor 7 into the exhalation hose 6.
These air pressure fluctuations lead to the release of the mucus in the lung 23 of the patient 21, because the positive and negative air pressure releases the possibly existing mucus in the lung 23, so that freely movable mucus particles develop. The negative pressure generated by the ventilating device is used to suck out the consumed breathing air 13 and causes these mucus particles to be carried out of the lung 23 and transported away with its help.
The tube 32 can also be attached to the ventilating hose 5 by means of an external and internal thread. The only factors which are decisive for the function are that the respiratory tract therapy device 31 can be connected to the ventilating hose 5 with an airtight seal and that the respiratory tract therapy device 31 can be removed from or connected to the ventilating hose 5 without delay and without complications.
According to
The respiratory tract therapy device 31 inserted into the ventilating hose 5 is thus subjected to the air flow forced out by the ventilating device 2 and the hose 33 vibrates inside the tube 32. When the consumed breathing air 13 is sucked out, the hose 33 closes completely, so that this breathing air 13 flows along the side of the hose 33.
The valve 19 channels the oxygen supply from ventilating device 2 directly to the patient via the bypass line 18 or draws the oxygen flow through the respiratory tract therapy device 31. The valve 19 can be moved manually from the outside to these two positions and thus forms a kind of branch for the oxygen flow.
The appliance 1 according to the present invention generates an intermittent air pressure fluctuation in all the embodiment variants described, which are transmitted to the bronchi or lung areas of the living being 21 and cause the mucus there to be released.
Number | Date | Country | Kind |
---|---|---|---|
10 2018 120 533.3 | Aug 2018 | DE | national |